Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals With Elevated Risk

The China PEACE SMARTER trial is a cluster ramdomized trial aiming to assess the effectiveness of village doctor-led tailored health management on risk reduction of high-risk individuals for cardiovascular disease.

Inclusion Criteria:Aged 35 or above;High CVD risk which defined as 10-year ASCVD risk ≥10% based on China-PAR prediction model;Ownership of a smart phone and being able to use apps;Being contracted with the local family doctor (village doctor);Willing to participate and able to sign informed consent.Exclusion Criteria:CVD history, including myocardial infarction (MI), stroke, heart failure, severe arrhythmia, or peripheral artery disease, or having received percutaneous coronary intervention (PCI) or coronary artery by-pass grafting operation (CABG);Severe illnesses, such as cancer, or severe hepatic and renal dysfunction;Women during pregnancy, lactation, or plan to have children in the next year;Having problems in cognition or communication, or limited daily activities.